MediClin pays a dividend again – Good occupancy rate during the first months of FY 2010

Offenburg, May 26, 2010 – At today’s annual general meeting of MEDICLIN Aktiengesellschaft in Frankfurt Dr. Ulrich Wandschneider, CEO, has expressed his satisfaction in his speech:

“The business development in recent years demonstrates, that our company is well positioned. The emphasis of our medical offerings lies on the neurosciences and psychological sciences, on orthopaedics and on specialised medical clinics, for example heard centres, clinics for special radiation therapy, eating disorders, diabetes, and otolaryngology – all areas with growth potential.” The development and realisation of integrated medical care concepts are essential parts of the corporate strategy of MediClin. Dr. Wandschneider continued: “Also in the future we will enter into patient-orientated co-operations, which allow an integrated treatment of the patient, for example through regional networking of clinics. And in 2010 we will search the market for applicable facilities, mainly in the acute-sector.”

In 2009 MediClin has invested 16.2 million EUR in modification and renovation, in the opening of medical care centres and modern medical equipment. About 120 thousand cases were treated and close to 2.5 million nursing days were provided in 2009. MediClin employs about 8,000 staff-members.
The annual general meeting of MediClin agreed to the proposal of the Management and Supervisory Board again to pay a dividend in the amount of 5 cent per share. The reasons for the dividend payout of about 2.4 million EUR in total are the satisfying development of last year’s business and the so far stable business development in 2010. The annual general meeting has also agreed to the election of the five supervisory board members who ran for re-election.
At the annual meeting about 88 per cent of MediClin’s share capital was represented. All items on the agenda which are subject to voting were passed by over 96 percent of the shareholders entitled to vote.

About MediClin AG (Ticker: MED; ISIN: DE0006595101)

MediClin AG is a nation-wide clinic operator and large provider of services in the area of Psycho- and Neurosciences as well as Orthopaedic. With 33 clinics and 7 nursing care facilities and 9 Medizinische Versorgungszentren (medical care units) in 11 federal states MediClin has a total capacity of approximately 7,900 beds. MediClins’ facilities include acute care clinics, i.e., general hospitals, special treatment facilities, specialised hospitals and clinics for post-acute treatment and medical rehabilitation. MediClin has approximately 8,000 employees.